After 30 years of listing, employees have something to say.
Release time:
2023-07-26
Zheng Xi (Logistics Department of Peak Supply Chain Company): At the beginning of
2019 , I joined Zhejiang Peak Supply Chain Company and felt very honored and happy. As a Jinhua, the peak in the hearts of Jinhua people still have a lot of weight, every time home, relatives or neighbors ask where to work now, I will proudly say, in the peak. Relatives or neighbors say they know that the influence and popularity of Spike is unquestionable, and I am lucky to work at Spike.
In the past few years, I have grown from a peak new employee to a peak old employee. At present, I am engaged in logistics scheduling, mainly arranging vehicles to complete the assigned transportation work. In this work, learning and understanding as a peak person, need to have all kinds of spirit and ability, but also very grateful to the company leaders and colleagues for my support and help, let me grow and progress. Good communication and teamwork are the greatest gains and feelings brought to me in the peak work. I will uphold the peak spirit and strive to grow.
The 30th anniversary of Jianfeng Group's listing, I am also particularly honored to be the same age as the anniversary of Jianfeng's listing. I hope that the future will grow and progress with the peak. May Jianfeng Group continue to innovate in the future and continue to develop steadily, continuously and healthily.
Lu Jiajing (Transportation Department of Peak Supply Chain Company):
May 3, 2017 was the most unforgettable day in my life. On this day, I really entered the society and became a new employee of Zhejiang Peak Supply Chain Company. "Aspire to rise to the top and climb the peak forever." When I shouted this slogan full of blood, I became a peak person. From that moment on, I became one with the spikes. After
, I was assigned to work in the transportation department. Since I have never been in contact with this aspect of business, I feel a lot of pressure after I arrived at the post, but the leaders and colleagues are very enthusiastic about me and have given detailed answers to all kinds of problems encountered in my work, which makes me familiar with the work process in a very short time, and the operation is also handy, and the business ability has been greatly improved. In 2018, with the trust of the leaders and the support of my colleagues, I became the driver of the general manager of the group. This was also a leap in my life and gave me further training. In three years, I have learned a lot of things, whether it is communication or people have made great progress, for which I am very grateful. Now I have returned to the peak supply chain company again and become the deputy director of the transportation department. The new position urges me to demand myself with higher standards and strive to repay the company with excellent results.
days passed day by day, along the way, all the way to appreciate, all the way to harvest. I am grateful that the company has provided me with a stage to show myself so that I can realize my dream. On this stage, no matter in the past, present or future, I will devote myself to my post more conscientiously. Spikes are the driving force for us to ride the wind and waves, spikes are the backing for us to march forward, and spikes are the ropes for us to climb bravely. Today we are proud of the spikes, tomorrow the spikes are proud of us. I breathe and share fate with spikes. 19
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31